Navigation Links
Lexicon to Report Second Quarter Financial Results on July 30, 2013
Date:7/23/2013

e operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information.  All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct preclinical and clinical development of its potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Information identifying such important factors is contained under "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2012, as filed with the Securities and Exchange Commission.  Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lexicon to Provide First Quarter 2012 Financial Results
2. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
3. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
4. Lexicon Pharmaceuticals to present at the Jefferies 2012 Global Healthcare Conference
5. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
6. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
7. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
8. Lexicon to Provide Second Quarter 2012 Financial Results
9. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results
10. Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access Conference
11. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014  ACI Clinical ( ... independent Data Monitoring Committees. Using this ... percent over industry standard costs and receive the ... leader in committee services. Leveraging a ... and contracting, charter development, statistical programming and meeting ...
(Date:8/21/2014)... , Aug. 21, 2014 CVS Caremark Corporation ... results, applicable Reference Yields and consideration payable in connection with ... on August 7, 2014 for (1) any and all of ... Notes") and (2) up to a maximum amount of its ... and 5.750% Senior Notes due 2017 (collectively, the "Maximum Tender ...
(Date:8/21/2014)... Aug. 21, 2014  Cyberonics, Inc. (NASDAQ: CYBX ... 2014.  Quarterly highlights 1   ... to the first quarter of fiscal 2014, and other achievements, ... an increase of 6.8%; , Strong international net sales ... currency basis; , U.S. net product sales reached a ...
Breaking Medicine Technology:ACI Clinical: Innovation and Savings in Data Safety Monitoring Committees 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16
... A combination of three drugs used worldwide as the standard ... danger of death or hospitalization, and should not be used ... to the surprising results of a rigorous independent study. ... the New England Journal of Medicine to coincide ...
... /PRNewswire-iReach/ -- Denton Vacuum LLC, a leading ... new website that guides visitors to information ... and navigation mirror what it,s like to work with ... business and technical drivers," says Rod Moore, Denton,s president. ...
Cached Medicine Technology:First, do no harm: Study finds danger in standard treatment for a serious lung disease 2First, do no harm: Study finds danger in standard treatment for a serious lung disease 3First, do no harm: Study finds danger in standard treatment for a serious lung disease 4Denton Vacuum's New Website Organizes Thin-Film Technology Information By Industry 2
(Date:8/22/2014)... August 22, 2014 The world’s largest, ... recently registered its two millionth member, and it has ... , Billionairefish.com is a dating website for the rich ... date. The dating website caters like-minded people who are ... site for the rich , this is the place ...
(Date:8/22/2014)... 2014 AttorneyOne.com, a recognized authority on ... information from the FDA on Diamondback 360 Peripheral ... announced on August 19, that certain lots of the ... (Part number 7-10003), by Cardiovascular Systems, are recalled ... could fracture during use and could possibly block blood ...
(Date:8/22/2014)... 22, 2014 On October 10, ... Canada to present an in-depth workshop on mindfulness ... headquarters. In the one-day workshop, participants will learn ... their biofeedback practice. , According to Dr. Khazan, ... help people control their physiological responses. However, extensive ...
(Date:8/22/2014)... to naysayers who are being skeptical about the success ... therapy LA specialist has firmly stated that the new ... well researched science and nothing to do with medical ... breakthrough technology which focuses on healing and repair of ... The Managing Director of one of the top PRP ...
(Date:8/22/2014)... Top10BestSEOHosting.com has recently compared many SEO hosting ... is one of the most recommended suppliers for ... hosting products. , Top10BestSEOHosting.com’s researchers look at ... technology, product availability and online service, ease of ... , “We believe that JustHost is one ...
Breaking Medicine News(10 mins):Health News:Rich Men & Women Dating Site Billionairefish.com Exceeds Two Million Members 2Health News:Rich Men & Women Dating Site Billionairefish.com Exceeds Two Million Members 3Health News:Diamondback 360 Peripheral Orbital Atherectomy System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Mindfulness Expert and Author Dr. Inna Khazan to Present One-day Workshop In Montreal on Integrating Mindfulness Based Skills Into a Biofeedback Practice 2Health News:Mindfulness Expert and Author Dr. Inna Khazan to Present One-day Workshop In Montreal on Integrating Mindfulness Based Skills Into a Biofeedback Practice 3Health News:MetroMD With The Help Of PRP Therapy Helps People Fight Hip Injuries 2
... who were treated with male hormone suppression therapy and ... to high levels of other illnesses did not experience ... 23 issue of JAMA. , Several studies have documented ... (AST) is combined with external beam radiation therapy (RT) ...
... American Heart Month, which is just ahead in February, ... and Prevention (CDC) shows that, since 1999, coronary heart ... 25.8 percent and 24.4 percent, respectively. This means ... reducing deaths from coronary heart disease has been achieved, ...
... in African-American and Caucasian men, researchers reported in Circulation: ... Veterans Affairs study included 15,660 participants and is the ... mortality. , It is important to emphasize that it ... brisk walking to attain the associated health benefits. ...
... a patients risk for heart disease, stroke and other ... could gauge risk of overall ,or global, CVD and ... to a study published in Circulation: Journal of the ... well suited for use by office-based primary care physicians, ...
... Leger Joins Agency as Executive Vice President, Managing Director, ... a leading healthcare,communications network, announced that Marcy Leger has ... Euro RSCG Life LM&P New,York, as a result of ... David Paragamian, Partner, President of Euro RSCG Life LM&P ...
... HEIGHTS, Mich., Jan. 22 On February 18, ... at 33045 Hamilton Court,Farmington Hills, Michigan. The Farmington ... an intimate, small campus, community-style setting.,This approximately 7,500 ... offering morning, afternoon and evening classes in medical,assisting ...
Cached Medicine News:Health News:Combination therapy improves survival for certain prostate cancer patients 2Health News:Heart and stroke death rates steadily decline; risks still too high 2Health News:Heart and stroke death rates steadily decline; risks still too high 3Health News:Heart and stroke death rates steadily decline; risks still too high 4Health News:Daily exercise dramatically lowers men's death rates 2Health News:Daily exercise dramatically lowers men's death rates 3Health News:A simplified scoring system may predict overall CVD risk, individual CVD components risk 2Health News:Euro RSCG Life LM&P Announces Growth of Leadership Team 2Health News:Dorsey Schools, Detroit Area's Preeminent Career Training School, Opens a Fifth Campus in Farmington Hills 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: